Gopten (Trandolapril)

Trandolapril inhibits the conversion of angiotensin I to angiotensin II, leading to vasodilation, reduced aldosterone secretion, and ultimately lower blood pressure.

Gopten is commonly prescribed for hypertension, chronic heart failure, and for ventricular remodeling after a myocardial infarction.

Gopten is classified as pregnancy category D, meaning it should only be used during pregnancy if the potential benefits outweigh the risks to the fetus.

The most frequently reported side effects include a dry cough, dizziness, headache, and fatigue.

Serious reactions such as angioedema, severe hypotension, or sudden worsening of kidney function should be evaluated by a healthcare professional promptly.

Patients on Gopten should have periodic assessments of serum creatinine and estimated glomerular filtration rate (eGFR) to detect any decline in renal function.

Avoid using Gopten together with aliskiren in diabetic patients, potassium‑sparing diuretics, or another ACE inhibitor or ARB.

NSAIDs can reduce the antihypertensive effect of Gopten and may impair kidney function, so they should be used with caution and under medical advice.

Because Gopten can increase serum potassium, patients should avoid high‑potassium foods or supplements unless directed by a healthcare provider.

Gopten contains trandolapril, which has a long half‑life and is often dosed once daily; its pharmacologic profile is similar to other ACE inhibitors but may vary in potency and side‑effect frequency.

Patients with moderate to severe hepatic impairment may require dose adjustment and close monitoring, as liver disease can affect drug metabolism.